434 related articles for article (PubMed ID: 30208561)
1. FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells.
Torres Á; Arriagada V; Erices JI; Toro MLÁ; Rocha JD; Niechi I; Carrasco C; Oyarzún C; Quezada C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208561
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells.
Torres A; Vargas Y; Uribe D; Jaramillo C; Gleisner A; Salazar-Onfray F; López MN; Melo R; Oyarzún C; San Martín R; Quezada C
Oncotarget; 2016 Oct; 7(41):67373-67386. PubMed ID: 27634913
[TBL] [Abstract][Full Text] [Related]
3. FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1.
Garrido W; Muñoz M; San Martín R; Quezada C
Biochem Biophys Res Commun; 2011 Jul; 411(1):62-8. PubMed ID: 21708136
[TBL] [Abstract][Full Text] [Related]
4. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.
Peigñan L; Garrido W; Segura R; Melo R; Rojas D; Cárcamo JG; San Martín R; Quezada C
Neurochem Res; 2011 Aug; 36(8):1397-406. PubMed ID: 21544552
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.
Xu X; Zheng Y; Luo L; You Z; Chen H; Wang J; Zhang F; Liu Y; Ke Y
Cell Death Dis; 2024 May; 15(5):318. PubMed ID: 38710703
[TBL] [Abstract][Full Text] [Related]
6. 5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells.
Quezada C; Garrido W; Oyarzún C; Fernández K; Segura R; Melo R; Casanello P; Sobrevia L; San Martín R
J Cell Physiol; 2013 Mar; 228(3):602-8. PubMed ID: 22833450
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Garrido W; Rocha JD; Jaramillo C; Fernandez K; Oyarzun C; San Martin R; Quezada C
Curr Drug Targets; 2014; 15(10):931-42. PubMed ID: 25174341
[TBL] [Abstract][Full Text] [Related]
8. Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells.
Jin F; Zhao L; Guo YJ; Zhao WJ; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Feng J; Jiang XB; Zhao HY
Brain Res; 2010 Jun; 1336():103-11. PubMed ID: 20388502
[TBL] [Abstract][Full Text] [Related]
9. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
Declèves X; Fajac A; Lehmann-Che J; Tardy M; Mercier C; Hurbain I; Laplanche JL; Bernaudin JF; Scherrmann JM
Int J Cancer; 2002 Mar; 98(2):173-80. PubMed ID: 11857404
[TBL] [Abstract][Full Text] [Related]
11. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.
Benyahia B; Huguet S; Declèves X; Mokhtari K; Crinière E; Bernaudin JF; Scherrmann JM; Delattre JY
J Neurooncol; 2004 Jan; 66(1-2):65-70. PubMed ID: 15015771
[TBL] [Abstract][Full Text] [Related]
13. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
15. Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness.
Niechi I; Uribe-Ojeda A; Erices JI; Torres Á; Uribe D; Rocha JD; Silva P; Richter HG; San Martín R; Quezada C
Cells; 2019 Oct; 8(11):. PubMed ID: 31671624
[TBL] [Abstract][Full Text] [Related]
16. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
18. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
[TBL] [Abstract][Full Text] [Related]
19. A
Rocha JD; Uribe D; Delgado J; Niechi I; Alarcón S; Erices JI; Melo R; Fernández-Gajardo R; Salazar-Onfray F; San Martín R; Quezada Monrás C
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012307
[TBL] [Abstract][Full Text] [Related]
20. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
